<html>
<head>PUBMED IDs for NB-3</head>
<body bgcolor='#C5F0F2'><h1>NB-3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7685595/'>Tyrosine kinase activity of the ret proto-oncogene products in vitro.</a> June 15  1993<br><a href='https://pubmed.ncbi.nlm.nih.gov/7811232/'>Alternative splicing of the ret proto-oncogene at intron 4.</a> December 30  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8724659/'>Nitric oxide synthase expression in human neuroblastoma cell line induced by cytokines.</a> March 22  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9168934/'>TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin.</a> April 28  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/11013081/'>Human NB-2 of the contactin subgroup molecules: chromosomal localization of the gene (CNTN5) and distinct expression pattern from other subgroup members.</a> October 3  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15735675/'>Domain-specific function of ShcC docking protein in neuroblastoma cells.</a> March 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15802787/'>Significance of survivin mRNA expression in prognosis of neuroblastoma.</a> April 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15802733/'>Risks of gene therapy should be weighed against lack of alternatives for many diseases.</a> April 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16142320/'>Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.</a> September 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16151587/'>Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.</a> September 10  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17143535/'>Notch signaling in gastrointestinal tract (review).</a> December 5  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17409494/'>A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.</a> April 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17505515/'>Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.</a> May 17  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18807141/'>Distinct morphological and immunohistochemical features and different growth rates among four human neuroblastomas heterotransplanted into nude mice.</a> September 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18807132/'>Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia.</a> September 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19142648/'>LRRK2 and neurodegeneration.</a> April 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19320641/'>RET protein promotes non-adherent growth of NB-39-nu neuroblastoma cell line.</a> July 9  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19698702/'>Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19963143/'>Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.</a> December 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20576524/'>Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.</a> March 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21622556/'>Receptor-like protein-tyrosine phosphatase Î± enhances cell surface expression of neural adhesion molecule NB-3.</a> September 17  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21622546/'>Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.</a> December 30  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22466570/'>Vitamin K3 analogs induce selective tumor cytotoxicity in neuroblastoma.</a> July 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22476102/'>Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.</a> July 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23563570/'>Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.</a> October 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24481548/'>Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells.</a> October 29  2014<br></body></html>
